Abstract:Transition metal complexes with substituted high affinity mixed ligands as potential anticancer agents can overcome the drawbacks of platinum-based drugs that are currently being marketed. Here, a new watersoluble asymmetric binuclear iminodiacetato-zinc(II) complex [Zn-2(ida)(phen)(3)(NO3)]center dot NO3 center dot 5H(2)O (1) with a phenanthroline ligand has been synthesized and fully characterized with a wide range of analytical techniques including single crystal X-ray diffraction as well as spectroscopic techniques, such as FT-IR, UV/Vis, photoluminescence spectroscopy, and furthermore by elemental and thermogravimetric analyses. Moreover, unprecedented (H2O)(10) water clusters consisting of a quasi-planar tetramer and six dangling water molecules were observed in the void space of 3D supramolecular assemblies. The conversion behavior of (1) into two monomeric species [Zn(ida)(phen)(H2O)] (2) and [Zn(phen)(2)(H2O)(2)](2+) (3) in aqueous solution was first studied by solid-state/solution NMR, ESI-MS, and solution UV/vis spectra. Next, these zinc(II) complexes (1-3), a mixture of (2) and (3) (mole ratio 1/1), ligands (phen and ida) and zinc ions (ZnCl2 and ZnSO4) were further evaluated for the in vitro cytotoxic profile in human hepatoma cell lines (HepG(2) and SMMC-7721). We found that complex (1) effectively inhibited the proliferation of hepatocellular carcinoma cells, which is similar to a mixture of (2) and (3) in a 1 : 1 molar ratio, and IC50 values of (1) were almost about 20-50% of (2) or (3). Therefore, this binuclear complex (1) mainly acts as a cooperative inhibitor with complexes (2) and (3) toward tumor growth in solution. We further extended the preliminary research of complex (1) and found that (1) could induce cell cycle arrest at the G0/G1 phase. Additionally, overdosing on (1) exhibited low toxicity of mice (LD50 of (1) in ICR mice = 736 mg kg(-1), with 95% confidence interval 635-842 mg kg(-1)). In conclusion, complex (1) with a high antitumor activity and low toxicity provides a new strategy for the treatment of liver cancer.

Synthesis and Crystal Structure of Some Transition Metal Complexes with A Novel Bis-Schiff Base Ligand and Their Antitumor Activities

Transition metal manganese(II), nickel(II), copper(II) and zinc(II) complexes of a new Schiff base ligand: Synthesis, characterization and antitumor activity studies

The Crystal Structures of Copper(ii), Manganese(ii), and Nickel(ii) Complexes of a (Z)-2-hydroxy-n′-(2-oxoindolin-3-ylidene) Benzohydrazide—potential Antitumor Agents

Synthesis and Study on Antitumor Activity of Butane-2,3-diylidene Dibenzohydrozide Schiff Bases

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, crystal structures and anticancer studies of Ni (II), Co (III) and Zn (II) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, Structural Characterization and Preliminary Biological Studies of Several Heterocyclic Transition Metal Carbonyl Complexes

Syntheses, Crystal Structures and Anticancer Activities of Three Novel Transition Metal Complexes with Schiff Base Derived from 2-Acetylpyridine and L-Tryptophan

An Asymmetric Binuclear Zinc(Ii) Complex With Mixed Iminodiacetate And Phenanthroline Ligands: Synthesis, Characterization, Structural Conversion And Anticancer Properties

Synthesis, Crystal Structure and Anticancer Activity of 4-Chloro-2-methoxybenzoic Acid Transition Metal Complexes

Novel tetranuclear grid-like Zn(II) complexes derived from dihydrazone pyrimidine derivatives as antitumor agents

Synthesis, Crystal Structure, DNA/bovine Serum Albumin Binding and Antitumor Activity of Two Transition Metal Complexes with 4‐acylpyrazolone Derivative

Metal and structure tuned in vitro antitumor activity of benzimidazole-based copper and zinc complexes

Synthesis and Structure Elucidation of Two Essential Metal Complexes: In-Vitro Studies of Their BSA/HSA-Binding Properties, Docking Simulations, and Anticancer Activities

Crystal Structures and Anticancer Activities of Five Novel Pyrazolone-Enamine Transition Metal Complexes with 4-Benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one

Synthesis, Characterization, and Anti-Tumor Activities of Some Transition Metal(ii) Complexes with Podophyllic Acid Hydrazide

Synthesis, characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives

Synthesis of Novel Cu(II), Co(II), Fe(II), and Ni(II) Hydrazone Metal Complexes as Potent Anticancer Agents: Spectroscopic, DFT, Molecular Docking, and MD Simulation Studies

Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes: DNA-binding and antitumor activity.

Five Novel Dinuclear Copper(ii) Complexes: Crystal Structures, Properties, Hirshfeld Surface Analysis and Vitro Antitumor Activity Study

Synthesis, Crystal Structures and Cytotoxic Activity of Mononuclear Nickel(ii) and Dinuclear Zinc(ii) Complexes with Ligand Derived from S-benzyldithiocarbazate